Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yinqiao Baidu Tablet for Wind-Heat Common Cold
CTR20140388Phase 3Completed
- Sponsor
- Beijing Tianli Zhengyuan Pharmaceutical Technology Development
- Start
- May 2014
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Yinqiao Baidu Tablet in nasopharyngitis, sponsored by Beijing Tianli Zhengyuan Pharmaceutical Technology Development. Started May 2014; status: completed.
02
Drugs
Yinqiao Baidu Tablet
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on CTR20140388.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140388.